10.1016/0014-2999(83)90327-8 Warter JM, Brandt C, Marescaux C, Rumbach L, Micheletti G, Chabrier G, Krieger J, Imler M: The renal origin of sodium valproate-induced hyperammonemia in fasting humans
[154] developed a multifunctional NPs, PPD/PHDP@siTGF-, designed with pH-responsive size reduction, charge reversal, and ROS-sensitive degradable properties to deliver siTGF- for tumor oxidationchemotherapy combined with TME remodeling
On the other hand, albumin levels in the blood are indicative of the liver's ability to synthesize this protein (Moghadam et al
While no approved protocol currently exists for this specific combination, the underlying science suggests that multi-pathway approaches targeting amylin, GIP, and GLP-1 receptors simultaneously may offer superior metabolic benefits compared to single-pathway interventions
Am J Resp Critical Care Medicine, 2017
Research Disclaimer: Mention of ongoing research directions is provided for informational purposes only and should not be interpreted as suggesting that injectable glutathione is appropriate for treating any specific medical condition